Publications by authors named "Pavan Kumar Dhanyamraju"

Claim this Profile
D
Drug resistance mechanisms in cancers: Execution of pro-survival strategies.
Pavan Kumar Dhanyamraju

J Biomed Res· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomedicine Strategies for Targeting Tumor Stroma.
Mei-Chi Su, Susheel Kumar Nethi, Pavan Kumar Dhanyamraju, Swayam Prabha

Cancers (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisiting the melanomagenic pathways and current therapeutic approaches.
Pavan Kumar Dhanyamraju, Solomon Rotimi, Priyanjali Bhattacharya, Trupti N Patel

Mol Biol Rep· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-Tolerant Persister Cells in Cancer Therapy Resistance.
Pavan Kumar Dhanyamraju, Todd D Schell, Shantu Amin, Gavin P Robertson

Cancer Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Protein Translation in Melanoma by Inhibiting EEF-2 Kinase Regulates Cholesterol Metabolism though SREBP2 to Inhibit Tumour Development.
Saketh S Dinavahi, Yu-Chi Chen, Raghavendra Gowda, Pavan Kumar Dhanyamraju, Kishore Punnath

Int J Mol Sci· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma therapeutics: a literature review.
Pavan Kumar Dhanyamraju, Trupti N Patel

J Biomed Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of aberrant Sonic hedgehog signaling pathway in cancers and developmental anomalies.
Trupti N Patel, Pavan Kumar Dhanyamraju

J Biomed Res· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell-free fetal DNA testing and its correlation with prenatal indications.
Jing-Wei Wang, Yong-Nan Lyu, Bin Qiao, Yan Li, Yan Zhang, Pavan Kumar Dhanyamraju

BMC Pregnancy Childbirth· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual targeting of MTOR as a novel therapeutic approach for high-risk B-cell acute lymphoblastic leukemia.
Zheng Ge, Chunhua Song, Yali Ding, Bi-Hua Tan, Dhimant Desai, Pavan Kumar Dhanyamraju

Leukemia· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic Basis for In Vivo Therapeutic Efficacy of CK2 Inhibitor CX-4945 in Acute Myeloid Leukemia.
Morgann Klink, Mohammad Atiqur Rahman, Chunhua Song, Pavan Kumar Dhanyamraju, Melanie Ehudin

Cancers (Basel)· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional Regulation of PIK3CD and PIKFYVE in T-Cell Acute Lymphoblastic Leukemia by IKAROS and Protein Kinase CK2.
Elanora Dovat, Chunhua Song, Tommy Hu, Mohammad Atiqur Rahman, Pavan Kumar Dhanyamraju

Int J Mol Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medulloblastoma: "Onset of the molecular era".
Pavan Kumar Dhanyamraju, Trupti N Patel, Sinisa Dovat

Mol Biol Rep· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia.
Chunhua Song, Zheng Ge, Yali Ding, Bi-Hua Tan, Dhimant Desai, Pavan Kumar Dhanyamraju

Blood· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PI3K/AKT Pathway Inhibitor ISC-4 Induces Apoptosis and Inhibits Growth of Leukemia in Preclinical Models of Acute Myeloid Leukemia.
Charyguly Annageldiyev, Su-Fern Tan, Shreya Thakur, Pavan Kumar Dhanyamraju, Srinivasa R Ramisetti

Front Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of Small GTPase Rab20 by Ikaros in B-Cell Acute Lymphoblastic Leukemia.
Jonathon L Payne, Chunhua Song, Yali Ding, Pavan Kumar Dhanyamraju, Yevgeniya Bamme

Int J Mol Sci· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional Regulation of Genes by Ikaros Tumor Suppressor in Acute Lymphoblastic Leukemia.
Pavan Kumar Dhanyamraju, Soumya Iyer, Gayle Smink, Yevgeniya Bamme, Preeti Bhadauria

Int J Mol Sci· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway.
Rajeev Singh, Pavan Kumar Dhanyamraju, Matthias Lauth

Oncotarget· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.
Philipp Schneider, Juan Miguel Bayo-Fina, Rajeev Singh, Pavan Kumar Dhanyamraju, Philipp Holz

Nat Commun· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of a novel actin-dependent signal transducing module allows for the targeted degradation of GLI1.
Philipp Schneider, Juan Miguel Bayo-Fina, Rajeev Singh, Pavan Kumar Dhanyamraju, Philipp Holz

Nat Commun· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histone deacetylase 6 represents a novel drug target in the oncogenic Hedgehog signaling pathway.
Pavan Kumar Dhanyamraju, Philipp Simon Holz, Florian Finkernagel, Volker Fendrich, Matthias Lauth

Mol Cancer Ther· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis